相似文献
1
Hereditary hemorrhagic telangiectasia presenting as a recurrent epistaxis in an adolescent: A case report.
World J Clin Pediatr. 2021 Jan 9;10(1):1-6. doi: 10.5409/wjcp.v10.i1.1.
2
Hereditary hemorrhagic telangiectasia in a 42-year-old Ethiopian man presenting with severe anemia and high-output heart failure: A case report with literature review.
Clin Case Rep. 2023 Jul 12;11(7):e7694. doi: 10.1002/ccr3.7694. eCollection 2023 Jul.
3
Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.
Otolaryngol Head Neck Surg. 2020 Jan;162(1):8-25. doi: 10.1177/0194599819889955.
4
Clinical Practice Guideline: Nosebleed (Epistaxis).
Otolaryngol Head Neck Surg. 2020 Jan;162(1_suppl):S1-S38. doi: 10.1177/0194599819890327.
5
[Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
Rev Med Interne. 2015 Sep;36(9):623-5. doi: 10.1016/j.revmed.2014.11.004. Epub 2015 Jan 13.
6
Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
Auris Nasus Larynx. 2016 Aug;43(4):429-32. doi: 10.1016/j.anl.2015.12.001. Epub 2015 Dec 29.
7
New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
Am J Rhinol. 2006 Jan-Feb;20(1):87-90.
8
Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
Sci Rep. 2019 Aug 19;9(1):11986. doi: 10.1038/s41598-019-48502-9.
9
[Hereditary hemorrhagic telangiectasia: symptoms and diagnostic latency].
Laryngorhinootologie. 2021 Jun;100(6):443-452. doi: 10.1055/a-1408-5160. Epub 2021 Mar 24.
10
Hereditary hemorrhagic telangiectasia.
N Am J Med Sci. 2015 Mar;7(3):125-8. doi: 10.4103/1947-2714.153928.
引用本文的文献
1
Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab.
Case Rep Gastrointest Med. 2021 Jun 29;2021:2242178. doi: 10.1155/2021/2242178. eCollection 2021.
本文引用的文献
1
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
Ann Intern Med. 2020 Dec 15;173(12):989-1001. doi: 10.7326/M20-1443. Epub 2020 Sep 8.
2
Future treatments for hereditary hemorrhagic telangiectasia.
Orphanet J Rare Dis. 2020 Jan 7;15(1):4. doi: 10.1186/s13023-019-1281-4.
3
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.
Lancet. 2014 Feb 15;383(9917):614-21. doi: 10.1016/S0140-6736(13)62302-8. Epub 2013 Nov 20.
4
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children.
J Pediatr. 2013 Jul;163(1):179-86.e1-3. doi: 10.1016/j.jpeds.2013.02.009. Epub 2013 Mar 25.
5
High diagnostic and clinical impact of small-bowel capsule endoscopy in patients with hereditary hemorrhagic telangiectasia with overt digestive bleeding and/or severe anemia.
Gastrointest Endosc. 2010 Apr;71(4):760-7. doi: 10.1016/j.gie.2009.11.004. Epub 2010 Feb 18.
6
Hereditary haemorrhagic telangiectasia: a clinical and scientific review.
Eur J Hum Genet. 2009 Jul;17(7):860-71. doi: 10.1038/ejhg.2009.35. Epub 2009 Apr 1.
7
Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
Hum Mol Genet. 2007 Jul 1;16(13):1515-33. doi: 10.1093/hmg/ddm069. Epub 2007 Apr 9.
8
Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management.
Saudi Med J. 2007 Jan;28(1):11-21.
9
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
J Med Genet. 2006 Feb;43(2):97-110. doi: 10.1136/jmg.2005.030833. Epub 2005 May 6.
Zotero 插件
